Overview

Researchers randomly assigned 40 patients undergoing two-stage revision ACL reconstruction to receive either autologous iliac crest cancellous bone graft for tunnel grafting (control group; n=20) or silicate-substituted calcium phosphate in the form of sculptable microgranules (Actifuse MIS System, Baxter) as a bone graft substitute for tunnel augmentation (intervention group; n=20). Researchers assessed the patients’ functional outcomes using KT-1000 arthrometry, the Tegner score, the Lysholm score and the IKDC score after a minimum follow-up period of 2 years.

Patients who received silicate-substituted calcium phosphate had a shorter operative time vs autologous bone graft.

Read full article on Helio

Download “Bone graft substitute for tunnel filling improved ACL reconstruction outcomes”

Learn How We Can Help You Stay Active

Request a Consultation